IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sudeep Pharma IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Vadodara and caters to Advertising And Media sector. ICICI Securities , IIFL Securities are the merchant bankers of Sudeep Pharma IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th June 2025.
Sudeep Pharma IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
291.36 cr.
Sector: Advertising And Media
IPO so far:
10
Merchant Banker:
ICICI Securities
IPO by BRLM so far:
164
City:
Vadodara
IPO so far:
4
Revenue (annualised):
₹
459.27
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 26.56x
Sudeep Pharma IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
ICICI Securities Limited is the book-running lead manager of the Sudeep Pharma IPO. MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) is the Registrar for Sudeep Pharma IPO.
Sudeep Pharma IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sudeep Pharma IPO, based in Vadodara, operates in the Advertising And Media sector with a focus on Technology-led manufacturer specializing in excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Sudeep Pharma IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil
The IPO allotment date for Sudeep Pharma IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Sudeep Pharma IPO allotment status on the registrars website, MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) . Sudeep Pharma IPO refund dates are [●].
Sudeep Pharma IPO is expected to be listed on [●].
The upper price band for the Sudeep Pharma IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sudeep Pharma IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sudeep Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Sudeep Pharma IPO is finalised.
The merchant banker for Sudeep Pharma IPO is ICICI Securities Limited , IIFL Securities Limited . ICICI Securities Limited , IIFL Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sudeep Pharma IPO RHP for further details.
The registrar for Sudeep Pharma IPO is MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) . Investors can go to MUFG Intime India Private Limited (prev known as Linkintime India Private Limited) registrar website for IPO allotment status, refund processing, and other queries related to Sudeep Pharma IPO through their official website or helpline.
Sudeep Pharma IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 291.36 Cr.
Sector: Advertising And Media
IPO so far:
10
Merchant Banker:
ICICI Securities
IPO by BRLM so far:
164
City:
Vadodara
IPO so far:
4
Revenue (annualised):
₹ 459.27 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 26.56x
Sudeep Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sudeep Pharma Financial Review Page
Merchant Banker(s) of Sudeep Pharma IPO: ICICI Securities Limited , IIFL Securities Limited
Sudeep Pharma IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sudeep Pharma IPO listed at a listing price of against the offer price of .
The current market price of Sudeep Pharma is .
Why Us?
